Our proprietary Osmodex® drug delivery system incorporates various features that we deploy to modulate drug release and achieve the desired pharmacokinetic profile.
Osmodex® Our Proprietary Drug Delivery System
Our technology allows us to manufacture tablets with one or more active drugs, and in combinations of immediate release, controlled release, delayed release and extended release. Our proprietary Osmodex® drug delivery system is well suited to address certain limitations of existing therapies that have less than optimal efficacy or unfavorable side effect profiles as a result of formulation, pharmacokinetic profiles or other complexities.
Our research and development team has led the successful clinical development of approved NDAs for products incorporating our proprietary Osmodex® drug delivery system, including Allegra D®, venlafaxine HCl ER tablets, desvenlafaxine ER tablets, hydromorphone HCl ER tablets, methylphenidate HCl ER tablets and Osmolex ER™ (amantadine) tablets.